Although IFN-γ is an important marker of immunogenetioity following BCG vaccination, the potential application of our findings to the clinical testing of new vaccines for TB will depend on whether there is any correlation in vivo between the magnitude of the IFN-γ response to vaccination and protection against TB, which is currently not known. Here, IFNG is linked to tuberculosis.